Edesa Biotech Files Q2 2025 10-Q
Ticker: EDSA · Form: 10-Q · Filed: May 14, 2025 · CIK: 1540159
| Field | Detail |
|---|---|
| Company | Edesa Biotech, Inc. (EDSA) |
| Form Type | 10-Q |
| Filed Date | May 14, 2025 |
| Risk Level | medium |
| Sentiment | neutral |
Sentiment: neutral
Topics: 10-Q, biotech, financials
TL;DR
Edesa Biotech's Q2 2025 10-Q is in. Check financials.
AI Summary
Edesa Biotech, Inc. filed its 10-Q for the period ending March 31, 2025. The company reported financial results and provided updates on its business operations. Specific financial figures and operational details are available within the full filing.
Why It Matters
This filing provides investors with an update on Edesa Biotech's financial health and operational progress for the second quarter of fiscal year 2025.
Risk Assessment
Risk Level: medium — As a biotech company, Edesa Biotech faces inherent risks related to drug development, regulatory approvals, and market competition.
Key Players & Entities
- Edesa Biotech, Inc. (company) — Filer of the 10-Q
- March 31, 2025 (date) — End of the reporting period
- Stellar Biotechnologies, Inc. (company) — Former company name
- 20120120 (date) — Date of former company name change
FAQ
What is the reporting period for this 10-Q filing?
The reporting period for this 10-Q filing is the quarter ended March 31, 2025.
What was Edesa Biotech's former company name?
Edesa Biotech, Inc.'s former company name was Stellar Biotechnologies, Inc.
When did the company change its name from Stellar Biotechnologies, Inc.?
The company changed its name from Stellar Biotechnologies, Inc. on January 20, 2012.
What is Edesa Biotech's Standard Industrial Classification code?
Edesa Biotech's Standard Industrial Classification code is 2834, for Pharmaceutical Preparations.
What is the SEC file number for Edesa Biotech?
The SEC file number for Edesa Biotech is 001-37619.
Filing Details
This Form 10-Q (Form 10-Q) was filed with the SEC on May 14, 2025 regarding Edesa Biotech, Inc. (EDSA).